Licence for admission to hospital

If a patient wishes to continue the diacetylmorphine-assisted treatment outside the authorised centre, the FOPH is required to issue a licence for the admission to hospital.

Under the terms of Article 3e, paragraph 3 of the Narcotics Act (NarcA ; RS 812.121), diacetylmorphine may only be prescribed by suitable institutions. In exceptional cases, a licence may be granted to a non-specialist institution if this is the sole means by which a patient can continue their diacetylmorphine-assisted treatment. Such a licence issued is thus only valid for the duration of the patient’s stay.

Content of the request

A licence for admission to hospital can only be granted if the following conditions are met:

  • Evidence must be provided that this is an exceptional case.
  • Coordinated, interdisciplinary care must be available.
  • It must be clearly specified in the documentation that the prescription of diacetylmorphine may not be delegated.

The request for admission to hospital must be submitted on behalf of the patient by the treating physician at the diacetylmorphine-assisted treatment centre (“HeGeBe” centre) and the treating physician at the hospital.

No fee is charged for the licence for admission to hospital (Article 40, letter d NarcAO)

The form (PDF, 195 kB, 18.12.2020) must be sent to hegebe@hin.ch.

Further information

Diacetylmorphine-assisted (heroin-assisted) treatment

Diacetylmorphine (pharmaceutical heroin) substitution treatment is intended for individuals with a severe heroin addiction. It is administered in specialist centres.

Last modification 06.08.2021

Top of page

Contact

Federal Office of Public Health FOPH
Prevention Non-communicable diseases Division
Schwarzenburgstrasse 157
3003 Bern
Switzerland
Tel. +41 58 463 20 43
E-mail

Print contact

https://www.bag.admin.ch/content/bag/en/home/gesetze-und-bewilligungen/gesuche-bewilligungen/ausnahmebewilligungen-bewilligungen-betmg/bewilligungen-hegebe/bewilligungen-hegebe-hospitalisierungsbewilligung.html